AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice of public workshop; request for comments; correction.
SUMMARY:
The Food and Drug Administration is correcting a notice entitled “Advancing the Utilization and Supporting the Implementation of Innovative Manufacturing Approaches” that appeared in the Federal Register of April 24, 2023. The document announced a public workshop. The document was published with an incorrect topic for discussion. This document corrects that error.
FOR FURTHER INFORMATION CONTACT:
Lisa Granger, Office of Policy, Legislation, and International Affairs, Food and Drug Administration, 301–796–9115, Lisa.Granger@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
In the Federal Register of April 24, 2023, in FR Doc. 2023–08545 (88 FR 24807), on page 24808, the following correction is made:
- On page 24808, in the second column, in Section II, “Topics for Discussion at the Public Workshop,” the fifth topic, “Science- and risk-based approaches for developing and accessing innovative technologies across platform products and sites to streamline adoption.” is corrected to read “Science- and risk-based approaches for developing and assessing innovative technologies across platform products and sites to streamline adoption.”
Dated: April 26, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–09206 Filed 5–1–23; 8:45 am]
BILLING CODE 4164–01–P